Related Experiment Video
Updated: Aug 18, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Chromosomal instability in mouse metastatic pancreatic cancer--it's Kras and Tp53 after all
Jens T Siveke1, Roland M Schmid
12nd Department of Internal Medicine, Technical University of Munich, Klinikum rechts der Isar, Ismaningerstrasse 22, 81675 Munich, Germany. roland.schmid@lrz.tum.de
Abstract:
A human pancreatic cancer progression model from intraepithelial neoplasia to ductal adenocarcinoma has been proposed. This process has been modeled in the mouse by activation of mutant Kras in pancreatic progenitor cells. In this issue of Cancer Cell, present a modification of their initial model by introducing a mutant Tp53. This combination of genetic alterations leads to rapid and increased frequency of neoplasia progression resulting in pancreatic cancers that manifest chromosomal instability in the presence of apparent intact telomeres. These findings introduce Tp53-mediated chromosomal instability as key event for carcinoma development in this mouse model.
Related Concept Videos
The Ras Gene
Ras is a superfamily...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancers Originate from Somatic Mutations in a Single Cell

